(Q43840047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Pietro Andreone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Carmela Cursaro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Gramenzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Biselli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Lorenzini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Felline

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Fiorino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L Di Giammarino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Porzio

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Galli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Bernardi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

306-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

The treatment of chronic viral hepatitis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

10.1046/J.1365-2893.2003.00449.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference